An article in the Wall Street Journal (September 13, 2013) describes supply problems for antidotes for Sarin due to manufacturing issues, that result in less than the stated dosage, in prefilled syringes made by Pfizer. The impact is possible erroneous doses in about 0.7% of the volume. Though the military has over 2.8 million doses in inventory, worries of stockouts have caused the Food and Drug Administration to grant extensions to use existing doses beyond their four year life span. Is the use of possibly expired but full dosages a reasonable option to less than the correct doses in current products ? How should stockpiles be shared between the military and civilian populations in an emergency ? How should manufacturer manufacturing be monitored to ensure quality and how should penalties be charged to sole suppliers of such critical products ?